Breast Reconstruction Rates Stable After Increase From 2005 to 2012

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

FRIDAY, Dec. 13, 2024 -- Breast reconstruction (BR) rates increased from 2005 to 2012, then stabilized from 2013 to 2017, according to a study published online in the December issue of Plastic and Reconstructive Surgery.

Robyn N. Rubenstein, M.D., from the Memorial Sloan Kettering Cancer Center in New York City, and colleagues examined longitudinal trends in BR rates in the United States using data for mastectomy cases with and without BR from 2005 through 2017 abstracted from the National Surgical Quality Improvement Program database; the Surveillance, Epidemiology, and End Results Program database; and the National Cancer Database (NCDB). Predictors of reconstruction were identified, and race and insurance distributions were assessed over time.

The researchers found that 32.7 percent of 1,554,381 mastectomy patients underwent BR. From 2005 to 2012, there was an increase in the annual reconstruction rates per 1,000 mastectomies (incidence rate ratios, 1.077 for the National Surgical Quality Improvement Program; 1.090 for the Surveillance, Epidemiology, and End Results Program; and 1.092 for the NCDB); from 2013 to 2017, rates stabilized. The likelihood of undergoing BR was increased for patients who were younger (aged ≤59 years), privately insured, with fewer comorbidities, and who underwent contralateral prophylactic mastectomy. The increase in BR rates was higher among Black and Asian patients than White patients over time (252.3, 366.4, and 137.3 percent, respectively). BR rates increased more among Medicaid and Medicare patients compared with privately insured patients (418.6, 302.8, and 125.3 percent, respectively).

"We have demonstrated a stabilization in breast reconstruction rates over the past decade despite legislation to increase public awareness of access to breast reconstruction," the authors write. "Simultaneously, we observed a reduction in some historical health care disparities, including race and insurance type."

Several authors disclosed ties to the pharmaceutical and medical device industries.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-12-14 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords